Logo image
Status epilepticus: immunologic and inflammatory mechanisms
Journal article   Peer reviewed

Status epilepticus: immunologic and inflammatory mechanisms

Chandrabhaga Miskin and Daphne M Hasbani
Seminars in pediatric neurology, v 21(3)
Sep 2014
PMID: 25510944

Abstract

Animals Cytokines - blood Disease Models, Animal Encephalitis - etiology Humans Immune System - physiopathology Immunologic Factors - metabolism Immunologic Factors - therapeutic use Status Epilepticus - complications Status Epilepticus - immunology
Status epilepticus (SE) can be difficult to treat, particularly if refractory, and lead to significant morbidity and mortality. Prolonged seizures are also a risk factor for the subsequent diagnosis of epilepsy. Activation of the immune system and inflammation are areas of recent interest in the field of epilepsy, and there is growing evidence that these may be involved in the pathogenesis of ongoing SE and subsequent epileptogenesis. We review the current data on this topic in both animal models and human disease. We conclude that there is evidence suggesting a role for immunologic and inflammatory mechanisms in SE. Further research, especially human studies, is necessary to determine whether targeting the immune system would improve control of SE and prevent sequelae such as epileptogenesis.

Metrics

8 Record Views
22 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Clinical Neurology
Pediatrics
Logo image